GE HealthCare earnings: date and guidance
MyStockButler's October 2026 analysis: GE HealthCare's next results are expected on October 28, 2026. GE HealthCare's key watch is operational recovery and cash conversion.
What has GE HealthCare guided for 2026?
GE HealthCare can reach $100.55 by October 2029, a +44% return including dividends, if Patient Care Solutions recovers, China pricing holds and cash conversion improves. On July 29, 2026, management guided to 3.0%–4.0% organic growth, 15.4%–15.7% adjusted EBIT margin, $4.80–$5.00 adjusted EPS and $1,600 million of free cash flow. After GE HealthCare generated $180 million in first-half free cash flow, it needs $1,420 million in the second half.
| Period guided | Low | High | Date given | |
|---|---|---|---|---|
| Organic revenue growth | Year to Dec 2026 | 3.0% | 4.0% | Jul 29, 2026 |
| Adjusted EBIT margin | Year to Dec 2026 | 15.4% | 15.7% | Jul 29, 2026 |
| Adjusted EBIT margin expansion (bps) | Year to Dec 2026 | 10 | 40 | Jul 29, 2026 |
| Adjusted effective tax rate (ETR) | Year to Dec 2026 | 20.0% | 21.0% | Jul 29, 2026 |
| Adjusted EPS | Year to Dec 2026 | 4.80 | 5.00 | Jul 29, 2026 |
| Free cash flow | Year to Dec 2026 | 1,600 | 1,600 | Jul 29, 2026 |
What this means. The company’s adjusted earnings per share leaves out some 2025 tariff-refund benefits but includes a small 2026 tariff benefit, so it is not the same as ordinary earnings per share.
Did GE HealthCare keep its past promises?
The original 2025 promise produced a mixed result. In February 2025, management forecast organic growth of 2%–3% and adjusted EPS of US$4.61–US$4.75. It delivered 3.5% growth but adjusted EPS of US$4.59. Growth beat the original range, while earnings missed it. Tariffs and later guidance changes make the starting forecast the clearest accountability test.
What has GE HealthCare's last eight quarters shown?
The eight-quarter record also argues against judging a recovery from one comparison. March 2025 included the Nihon Medi-Physics gain, while June 2026 included the tariff refund. A durable recovery requires PCS to convert orders, margins to improve without refunds and cash conversion to strengthen.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,295 | 5,131 | 5,698 | 5,143 | 5,007 | 4,777 | 5,319 | 4,863 |
| Operating income | 739 | 515 | 827 | 653 | 654 | 629 | 801 | 676 |
| Net income | 561 | 389 | 589 | 446 | 486 | 564 | 720 | 470 |
| EPS, diluted | 1.24 | 0.85 | 1.29 | 0.98 | 1.06 | 1.23 | 1.57 | 1.02 |
| Cash from operations | 168 | 290 | 1,050 | 593 | 94 | 250 | 913 | 742 |
| = Free cash flow | 68 | 112 | 916 | 483 | 7 | 98 | 811 | 652 |
What should I watch in GE HealthCare's next results?
The first checkpoint is the scheduled October 28, 2026, third-quarter report. New orders indicate demand, but orders become useful only when GE HealthCare ships equipment, installs it, invoices customers and collects payment. The clearest operational sign would be a recovery in Patient Care Solutions while inflation becomes easier to absorb.